Dr. Robert M. Califf, distinguished cardiologist and medical researcher, has been confirmed by the U.S. Senate as the next U.S. Food and Drug Administration (FDA) Commissioner. President Barack Obama nominated Dr. Califf in September 2015.
The Society for Women’s Health Research (SWHR®) congratulates Dr. Califf. Having strongly supported his nomination and urged the Senate to confirm him, SWHR is pleased that he has been presented with this leadership role.
Dr. Califf joined the FDA as deputy commissioner earlier this year from Duke University in Durham, NC, where he had served as the vice chancellor of clinical and translational research and the director of the Duke Translational Medicine Institute (DTMI). In addition, he was a professor of medicine in the Division of Cardiology at the Duke University Medical Center, and the founding director of the Duke Clinical Research Institute (DCRI).
“Dr. Califf is a widely respected leader in the field of clinical research and will do an excellent job leading the FDA during this critical juncture,” said Phyllis Greenberger, MSW, SWHR President and CEO. “We congratulate Dr. Califf on his confirmation and look forward to working with him and the FDA to ensure that medical products are safe and effective for both women and minorities.”